Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02415270 · ClinicalTrials.gov registry record · NA
Switching to Reduced Oxidant or Nicotine Content Cigarettes in Smokers
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT02415270 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 37 participants.
The verdict
NCT02415270, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The overall objectives of this clinical study are to determine in smokers the short term effects of switching to tobacco products that deliver low levels of nicotine or reactive oxygen/nitrogen species (ROS/RNS) on smoking behavior and biomarkers of tobacco smoke exposure and oxidative stress.
Interventions
- OTHER Control
- OTHER Reduced Nicotine Cigarettes
- OTHER Reduced ROS/RNS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02415270
The ClinicalTrials.gov registry entry for NCT02415270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT02415270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02415270 about?
NCT02415270 is a clinical study titled "Switching to Reduced Oxidant or Nicotine Content Cigarettes in Smokers". The overall objectives of this clinical study are to determine in smokers the short term effects of switching to tobacco products that deliver low levels of nicotine or reactive oxygen/nitrogen species (ROS/RNS) on smoking behavior and biomarkers of tobacco smoke exposure and oxidative stress.
What is the current status of trial NCT02415270?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2016-01. Estimated completion is 2017-01-01.
What interventions are being tested in trial NCT02415270?
The interventions under investigation include: Control (OTHER), Reduced Nicotine Cigarettes (OTHER), Reduced ROS/RNS (OTHER).
Who is sponsoring clinical trial NCT02415270?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.